Supernus to Participate in the Wells Fargo Healthcare Conference

<p>ROCKVILLE, Md., Aug. 31, 2023 (GLOBE NEWSWIRE) &#8212; Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will participate in a fireside chat at the 2023 Wells Fargo Healthcare Conference [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/supernus-to-participate-in-the-wells-fargo-healthcare-conference/">Supernus to Participate in the Wells Fargo Healthcare Conference</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>